R sestoration of cerebral blood flow (CBF) with thrombolytic agents and cerebroprotection with N-methyl-D-aspartate (NMDA) receptor antagonists have great potential as therapies for acute ischemic stroke because both reperfusion and cytoprotective therapy reduce infarct size in animal stroke models. [1] [2] [3] [4] [5] [6] Although reperfusion after a brief duration These studies could not distinguish the effects of NMDA antagonists from those of reperfusion because of the inability to monitor evolution of ischemic brain damage in vivo before and after reperfusion.
Diffusion-weighted magnetic resonance imaging (DWI) can identify within minutes after the onset of experimental stroke areas of brain tissue that are ischemic and likely to progress to infarction. [30] [31] [32] This technique has also recently been used within the first hours after stroke onset in humans.33 DWI measures the translational movement (Brownian motion or diffusion) of water in tissues. [34] [35] [36] Energy deficits and the failure of ion pumps associated with ischemia cause accumulation of intracellular sodium and water (cytotoxic edema), which presumably reduces the diffusion coefficient of water in the ischemic tissue and results in hyperintensity on DWI. 30 We previously demonstrated that DWI can quantitatively predict tissue destined for infarction within 30 In the present study, we used DWI, T2-weighted magnetic resonance imaging (T2WI) and dynamic contrast-enhanced perfusion magnetic resonance imaging (MRI) studies37-39 to assess the effects of postischemic administration of CNS 1102 on the evolution of brain injury during and after 3 hours of temporary ischemia in rats.
Materials and Methods
We studied 16 After the MRI studies, the animals were allowed to recover from the anesthesia, and no obvious behavioral effects were seen in animals surviving for 24 hours. Atdeficit; 1, failure to extend left forepaw fully; 2, circling to the left; 3, falling to the left; 4, no spontaneous walking with a depressed level of consciousness; and 5, dead. The animals were then anesthetized with an intraperitoneal injection of chloral hydrate (300 mg/kg) and decapitated. The brain was sectioned coronally at 2-mm intervals. Six sections containing the MCA territory were stained with a 2% solution of triphenyltetrazolium chloride (TTC) to identify infarcted tissue, fixed in formalin, and photographed.3244
Data from DWI, T2WI, perfusion MRI, and TTC studies were blindly analyzed by an observer unaware of the animals' experimental group. DWI and T2WI hyperintense regions in the ischemic hemisphere were determined by using a personal computer with image analysis software (OPTiMAs 3.0, Bioscan Products, Edmonds, Wash). Gray-scale maps corresponding to actual signal intensity on a pixel-by-pixel basis were displayed on the computer monitor. Areas in the ischemic hemisphere were assigned as lesions when their gray levels appeared to a blinded observer to be greater than those in the contralateral hemisphere. The hyperintense area (lesion area) was divided by the ipsilateral hemispheric area to obtain the percent hemispheric lesion area (%HLA). Photographs of TTC-stained sections were evaluated with a computer-assisted digitizer (Sigma-Scan V3.10, Jandel Scientific, Corte Madera, Calif; and Numonics 2200, Numonics, Montgomeryville, Pa). The area not stained red with TTC was considered a lesion (an infarction) and was divided by the ipsilateral hemispheric area to determine %HLA. The infarct volume (mm3) was calculated by using a numerical integration of the lesion areas for all the TTC sections per animal and the distance between them.
In the perfusion MRI studies, the signal intensity within a region of interest (ROI) (1.0 x 1.0x 2.0 mm3) in the upper sensorimotor cortex was bilaterally determined for each time point. The time from injection to the lowest signal intensity (time to nadir [TN] ) and the maximum decline in signal intensity from the baseline (signal intensity decline [SID]) were determined for each time-signal intensity curve. The delay in TN (DTN) and the relative SID (RSID) in the ischemic ROI compared with those in the contralateral ROI were used to semiquantitatively assess the perfusion state. The perfusion state in the ipsilateral MCA territory was also qualitatively graded compared with the contralateral MCA territory (perfusion scale): 0, no difference; 1, delayed transit of the contrast agent; 2, an incomplete decline in signal intensity within a part of the MCA territory; 3, an incomplete decline in signal intensity within the entire MCA territory; and 4, no decline in signal intensity in the entire MCA area. 37 For comparison of %HLA determined with DWI and TTC, a three-factor, repeated-measures analysis of variance (ANOVA) was performed, where a betweengroup factor was treatment (control and CNS 1102), and within-group factors were time of measurement (30 minutes, 3 hours, 3.5 hours, and 24 hours) and slices of measurement (slices A and B). T2WI %HLA before and after withdrawing the occluder was also analyzed with a three-factor, repeated-measures ANOVA. To compare physiological measurements and infarct volume, a two-factor, repeated-measures ANOVA and one-way ANOVA were used, respectively, depending on the numbers of factors and measurements in each animal. For comparison of the neurological grading scale, DTN, RSID, and the perfusion scale between control and CNS 1102-treated animals, the MannWhitney U test was used. Changes in DTN, RSID, and the perfusion scale before and after withdrawal of occluder were assessed with the Wilcoxon signed-rank test. Linear and Spearman regression analyses were used for correlating parametric and nonparametric data sets, respectively. All values are mean±SEM. A two-tail value of P<.05 was considered significant.
Results
Body weight, body temperature, blood pressure, and Po2 were normal and not different between the groups during the observation period. Arterial Pco2 was higher in treated rats than in control rats when the overall difference was tested (F1,14=6.50, P<.05). The difference was modest and not significant at baseline and 30 minutes after occlusion but was significant 30 minutes after withdrawal (32.3±1.4 mm Hg in CNS 1102-treated rats and 25.7±2.5 in controls; P<.05). Arterial pH was lower in the treated group than in the control group (F1,14=7.77, P<.02) and declined over time in both groups (F2,,4=7.63, P<.005). Ad hoc analysis revealed a significant difference only at 30 minutes after withdrawal (7.30±0.01 in CNS 1102-treated rats and 7.36±0.01 in controls; P<.02). To assess the effects of CNS 1102 on brain temperature, brain and rectal temperatures were concomitantly evaluated in two rats subjected to 3 hours of temporary occlusion. The animals received the same dose of CNS 1102 as the animals in the MRI study. Temperature was maintained by a heating pad, but they did not undergo the MRI protocol. Brain temperature, as monitored by a thermocouple implanted stereotactically into the striatum of the occluded hemisphere, was 37°C just after occlusion and remained unchanged during the entire 165 minutes of CNS 1102 treatment as did the rectal temperature.
In all rats, perfusion MRI studies demonstrated hypoperfusion in the right MCA territory at 3 hours before withdrawing the occluder. In all animals, ROI analyses demonstrated a delay in the transit of the contrast agent on the occluded side. Values of RSID and the perfusion scale before withdrawal of the occluder were significantly better in CNS 1102-treated rats than in control rats, suggesting milder hypoperfusion in the former. After withdrawal of the occluder. the perfusion abnormalities improved significantly in both groups, indicating successful reperfusion (Table 1 and Fig 1) .
At 30 minutes after occlusion, DWI revealed a large region of increased signal intensity in the ipsilateral MCA territory of all the control rats. These hyperintense lesions remained unchanged in size over the next 2.5 hours of occlusion and 30 minutes after withdrawal of the occluder. DWI studies at 30 minutes after occlusion showed that 7 of 10 rats treated with CNS 1102 had no detectable abnormality, 2 had lesions confined to the caudoputamen or a small cortical region, and 1 had an extensive lesion comparable to those detected in control rats. By 3 hours after occlusion, hyperintense areas were seen in 7 rats. After withdrawal of the occluder, the hyperintensity resolved completely in 1 of these rats, decreased in size in 4, and remained unchanged in 2 (Fig 2) .
T2WI studies detected no abnormalities at 30 minutes after occlusion. At 3 hours, before withdrawal, T2WI could not detect ischemic lesions or underestimated the size of the ischemic lesion by approximately half compared with the DWI studies. After withdrawal of the occluder, the T2WI lesion size remained unchanged in drug-treated rats but increased in control rats.
Three control but no treated rats died with massive brain edema and brain herniation before 24 hours. The neurological scale at 24 hours was 1.1+0.4 in the treated group, significantly better than the score in the control group (4.0±0.5; P<.005). Post mortem TTC studies demonstrated that all control rats had an extensive cerebral infarction encompassing almost the entire MCA territory and that the %HLA at slices A and B were significantly smaller in the CNS 1102 group (Table  2) . Three rats treated with CNS 1102 had no measurable infarction, 2 had a caudoputaminal infarction alone, 1 had a small cortical infarction alone, and the remaining 4 rats had both cortical and caudoputaminal infarctions. Total infarct volume in rats treated with CNS We used perfusion MRI studies to document hypoperfusion during arterial occlusion and to verify reperfusion after withdrawing the occluder. The perfusion MRI studies can provide quantitative data such as mean transit time, cerebral blood volume, and CBF, which is equal to the ratio of cerebral blood volume to the mean transit time, if intracapillary concentration of a contrast medium is calculated from signal intensities, the arterial input function is measured, and the y-fitting approach is applied to time-concentration curves.38394' Although such quantitative data could not be obtained in the present study, the semiquantitative and qualitative evaluations strongly suggested that vascular perfusion and, by inference, CBF during MCA occlusion were better in CNS 1102-treated rats than in saline-treated rats.
Although NMDA antagonists are not thought to have direct vasomotor actions, there is conflicting evidence concerning their effects on cerebral circulation. Park et a147 observed that MK-801 did not change the extent of the ischemic areas (defined as CBF less than 30 mL-100 g`' min') measured 40 minutes after MCA occlusion in deeply anesthetized and mechanically ventilated rats. They concluded that the anti-ischemic effects of MK-801 that they observed under the same experimental conditions5 could not be attributed to improvement of CBF. Likewise, Dezsi et aV28 found that MK-801 did not alter CBF at the periphery of the MCA territory after experimental stroke in cats.
On the other hand, MK-801 has been reported to alter regional CBF in unanesthetized animals,4849 and several recent studies have raised the possibilities that NMDA antagonists may improve CBF during arterial occlusion.29,49,50 A competitive NMDA antagonist, CGS-19755, increased CBF in both ischemic and nonischemic hemispheres 4 hours after arterial occlusion in rats. 51 In that study, CBF was measured after the animals recovered from anesthesia. Buchan et a129 observed that MK-801 significantly increased blood flow to ischemic brain in lightly anesthetized normotensive rats but not in spontaneously hypertensive rats, suggesting that the cerebroprotective effects of NMDA antagonists may result in part from improvements in CBF. Alternatively, by preventing cellular injury, NMDA antagonists may facilitate improvement of collateral circulation. In any case, effects on CBF appear to vary depending on the animal model being studied and, especially, the degree of anesthesia at the time CBF is measured.
In conclusion, intervention with CNS 1102 beginning shortly after the onset of ischemia prolonged the time window for effective reperfusion and possibly mitigated adverse effects resulting from late reperfusion. Successful restoration of blood flow, in turn, salvaged additional tissue. DWI offers a rapid and noninvasive way to monitor the effectiveness of both therapeutic strategies and should be adaptable to clinical studies of human stroke patients.
